v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Series A
Preferred Stock
Series A-1
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at May. 03, 2020
Balance (in Shares) at May. 03, 2020          
Issuance of common stock $ 2,293 6,006,826 6,009,119
Issuance of common stock (in Shares)     2,293,154      
Issuance of Series A-1 Preferred Stock, net of issuance costs $ 3,903,730 3,903,730
Issuance of Series A-1 Preferred Stock, net of issuance costs (in Shares) 628,930          
Subscription receivables $ (3,499,997) (499,998) (3,999,995)
Stock-based compensation expense 29,232 29,232
Net loss (2,530,462) (2,530,462)
Balance at Dec. 31, 2020 $ 403,733 $ 2,293 5,536,060 (2,530,462) 3,411,624
Balance (in Shares) at Dec. 31, 2020 628,930   2,293,154      
Issuance of common stock $ 16 99,982 99,998
Issuance of common stock (in Shares)     15,723      
Issuance of Warrants in connection with the issuance of the Series A-1 Preferred Stock (326,675) 326,675
Payment for Series A Preferred Stock subscribed 3,499,997 3,499,997
Payment for common stock subscribed 499,998 499,998
Issuance of Series A-1 Preferred Stock, net of issuance costs $ 3,904,872 3,904,872
Issuance of Series A-1 Preferred Stock, net of issuance costs (in Shares)   684,450        
Stock-based compensation expense 102,325 102,325
Net loss (2,612,353) (2,612,353)
Balance at Mar. 31, 2021 $ 3,903,730 $ 3,578,197 $ 2,309 6,565,040 (5,142,815) 8,906,461
Balance (in Shares) at Mar. 31, 2021 628,930 684,450 2,308,877      
Balance at Dec. 31, 2020 $ 403,733 $ 2,293 5,536,060 (2,530,462) 3,411,624
Balance (in Shares) at Dec. 31, 2020 628,930   2,293,154      
Conversion of Accrued Expenses to Equity in connection with the Business Combination          
Net loss           (8,126,451)
Balance at Sep. 30, 2021 $ 3,903,730 $ 3,578,197 $ 2,309 6,827,681 (10,656,913) 3,655,004
Balance (in Shares) at Sep. 30, 2021 628,930 684,450 2,308,877      
Balance at Dec. 31, 2020 $ 403,733 $ 2,293 5,536,060 (2,530,462) 3,411,624
Balance (in Shares) at Dec. 31, 2020 628,930   2,293,154      
Issuance of common stock $ 16 99,982 99,998
Issuance of common stock (in Shares)     15,723      
Issuance of Warrants in connection with the issuance of the Series A-1 Preferred Stock (32,667) 326,675
Payment for Series A Preferred Stock subscribed 3,499,997 3,499,997
Payment for common stock subscribed 499,998 499,998
Issuance of Series A-1 Preferred Stock, net of issuance costs $ 3,904,872 3,904,872
Issuance of Series A-1 Preferred Stock, net of issuance costs (in Shares)   684,450        
Stock-based compensation expense 470,878 470,878
Net loss (11,986,837) (11,986,837)
Balance at Dec. 31, 2021 $ 3,903,730 $ 3,578,197 $ 2,309 6,933,593 (14,517,299) (99,470)
Balance (in Shares) at Dec. 31, 2021 628,930 684,450 2,308,877      
Balance at Mar. 31, 2021 $ 3,903,730 $ 3,578,197 $ 2,309 6,565,040 (5,142,815) 8,906,461
Balance (in Shares) at Mar. 31, 2021 628,930 684,450 2,308,877      
Stock-based compensation expense       131,321   131,321
Net loss     (2,469,594) (2,469,594)
Balance at Jun. 30, 2021 $ 3,903,730 $ 3,578,197 $ 2,309 6,696,361 (7,612,409) 6,568,188
Balance (in Shares) at Jun. 30, 2021 628,930 684,450 2,308,877      
Stock-based compensation expense       131,320   131,320
Net loss (3,044,504) (3,044,504)
Balance at Sep. 30, 2021 $ 3,903,730 $ 3,578,197 $ 2,309 6,827,681 (10,656,913) 3,655,004
Balance (in Shares) at Sep. 30, 2021 628,930 684,450 2,308,877      
Balance at Dec. 31, 2021 $ 3,903,730 $ 3,578,197 $ 2,309 6,933,593 (14,517,299) (99,470)
Balance (in Shares) at Dec. 31, 2021 628,930 684,450 2,308,877      
Conversion of Series A Preferred Stock to common stock $ (3,903,730) (3,903,730)
Conversion of Series A Preferred Stock to common stock (in Shares) (628,930)          
Conversion of Series A-1 Preferred Stock to common stock $ (3,578,197) (3,578,197)
Conversion of Series A-1 Preferred Stock to common stock (in Shares)   (684,450)        
Issuance of common stock in connection with the Business Combination, net of issuance costs $ 10,635 14,335,619 14,346,254
Issuance of common stock in connection with the Business Combination, net of issuance costs (in Shares)     10,635,336      
Equity Issuance for fees in connection with the Business Combination $ 300 300
Equity Issuance for fees in connection with the Business Combination (in Shares)     300,000      
Proceeds from the PIPE Investment, net of issuance costs $ 1,293 7,260,926 7,262,219
Proceeds from the PIPE Investment, net of issuance costs (in Shares)     1,293,126      
Rollover Warrant exercise $ 2 5,072 5,074
Rollover Warrant exercise (in Shares)     1,891      
Repurchase for the Forward Share Purchase Agreement exercise $ (750) (7,651,575) (7,652,325)
Repurchase for the Forward Share Purchase Agreement exercise (in Shares)     (750,000)      
Pre-Funded Warrants exercise $ 1,294 (1,281) 13
Pre-Funded Warrants exercise (in Shares)     1,293,541      
Stock-based compensation expense 137,892 137,892
Net loss (6,616,541) (6,616,541)
Balance at Mar. 31, 2022 $ 15,083 21,020,246 (21,133,840) (98,511)
Balance (in Shares) at Mar. 31, 2022 15,082,771      
Balance at Dec. 31, 2021 $ 3,903,730 $ 3,578,197 $ 2,309 6,933,593 (14,517,299) $ (99,470)
Balance (in Shares) at Dec. 31, 2021 628,930 684,450 2,308,877      
RSU awards issued (in Shares)           119,965
Conversion of Accrued Expenses to Equity in connection with the Business Combination           $ 749,700
Net loss           (9,621,963)
Balance at Sep. 30, 2022 $ 23,536 26,343,404 (24,139,262) 2,227,678
Balance (in Shares) at Sep. 30, 2022 23,536,070      
Balance at Mar. 31, 2022 $ 15,083 21,020,246 (21,133,840) (98,511)
Balance (in Shares) at Mar. 31, 2022 15,082,771      
Stock-based compensation expense       90,188   90,188
Net loss (1,834,686) (1,834,686)
Balance at Jun. 30, 2022 $ 15,083 21,110,434 (22,968,526) (1,843,009)
Balance (in Shares) at Jun. 30, 2022 15,082,771      
Stock-based compensation expense       40,675   40,675
Proceeds from the July 2022 Public Offering, net     $ 8,333 4,442,715   4,451,048
Proceeds from the July 2022 Public Offering, net (in Shares)     8,333,334      
RSU awards issued     $ 120 (120)    
RSU awards issued (in Shares)     119,965      
Conversion of Accrued Expenses to Equity in connection with the Business Combination       749,700   749,700
Net loss (1,170,736) (1,170,736)
Balance at Sep. 30, 2022 $ 23,536 $ 26,343,404 $ (24,139,262) $ 2,227,678
Balance (in Shares) at Sep. 30, 2022 23,536,070